Session Details
[1-S]Inflammation pathophysiology from micro and macro perspectives: immune transformation, drug resistance, and pathological stress as triggers
Mon. Mar 16, 2026 10:10 AM - 11:40 AM JST
Mon. Mar 16, 2026 1:10 AM - 2:40 AM UTC
Mon. Mar 16, 2026 1:10 AM - 2:40 AM UTC
Room 2(A200)
Chair:Hiroyuki Takano(Chiba University Graduate School of Pharmaceutical Sciences), Hiromi Sato(Chiba University)
When inflammation and immune responses deviate from their inherent defensive functions, they undergo plastic changes that underlie diverse pathological states such as cancer, neurodegeneration, and infectious diseases. This dynamic responsiveness contributes to homeostasis at times, while promoting disease at others. We focus on the interplay between the breakdown of immune response and inflammatory stress control at the molecular level (micro) and resistance to drug therapy alongside systemic disease-modifying factors (macro). Through cutting-edge research in the nervous system, muscle tissue, and hematopoietic system, we will multifacetedly examine how the plasticity of inflammation and immunity influences biological functions and disease susceptibility, envisioning novel intervention strategies.
[1-S-20]Inflammation and the role of the peripheral glias in the microenvironment of metastatic brain tumors
*Hiromi Sato1 (1. Chiba University)
[1-S-21]The possible role of RTP4, a receptor chaperone protein/interferon stimulated gene, in chronic opioid use.
*Wakako Fujita1 (1. Juntendo University, Faculty of Pharmacy)
[1-S-22]Mitochondrial Potassium Channels and Muscular Inflammation
*Kazuho Sakamoto1 (1. Int. Univ. Health Welfare)
[1-S-23]Therapeutic Targeting of Epigenomic Dysregulation in Inflammation-Associated Myelodysplastic Syndrome (MDS)
*Kazumasa Aoyama Aoyama1 (1. Faculty of Pharmacy, Keio University)
[1-S-24]Mitochondrial protein C15ORF48 confers resistance to DNA-damaging anticancer agents.
*Noritaka Yamaguchi1, Yuki Takakura1, Hiroyuki Takano1 (1. Chiba University)
